November 2019 Issue

GO TO FULL ISSUE

Med Updates

Baqsimi
glucagon
A new nasal powder formulation for severe hypoglycemia

Gvoke
glucagon
New subcutaneous injection formulation available in a pre-filled syringe

Rybelsus
Semaglutide
Oral GLP-1 agonist for type 2 diabetes. It's the tablet version of injectable Ozempic.

OTHER MED UPDATES